VRAX

Conviction 76Scan · Mon, Aug 10, 2026

VRAX$2.88-3.36%

ResistanceSupportVol 14

Vol MA14 108.75K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Virax Biolabs Group LtdIn Vitro & In Vivo Diagnostic Substanceswww.viraxbiolabs.com ↗

Price2.88

Change-3.36%

Gap-0.67%

Rel volume0.00×

Avg volume763.36K

Avg $ vol2.9M

SMA 203.22

SMA 502.14

SMA 2000.7579

Price vs 50+34.68%

Price vs 200+279.98%

MA stackbullish

50/200 cross—

Supertrenddown · 4.12

RSI (14)50

MACD hist-0.13

MACD cross—

Stoch %K / %D26 / 23

ADX (14)47

+DI / −DI44 / 20

RSI divergence—

MACD divergence—

ATR %+16.64%

ADR %9.27%

52w high6.36

52w low0.1041

From 52w high-54.72%

Above 52w low+2666.57%

New 52w highNo

SqueezeOff

Bollinger width52.09%

%B0.30

Donchian pos20.44%

Donchian high4.16

Donchian low2.55

AVWAP (52w high)7.54

vs AVWAP high-61.81%

AVWAP (52w low)0.6768

vs AVWAP low+325.55%

OBV trendUp

Chaikin MF (20)0.30

Today vs 20d0.00×

Avg vol (14d)108.75K

Avg vol (20d)763.36K

Avg $ vol (20d)2.9M

Market cap—

RS 3m (vs SPY)+2101.71%

RS 6m (vs SPY)+1227.62%

RS line new highNo

Trend template7/8

Technical rank77.7

1 week-2.04%

1 month-29.41%

3 months+1584.21%

6 months+1170.96%

1 year+264.51%

YTD+650.00%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.63M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryIn Vitro & In Vivo Diagnostic Substances

ExchangeNasdaq

Shares out4.34M

Employees19

ListedThu, Jul 21, 2022

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction76 / 100

Pattern quality—

Tech rank77.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.97

Support0.1385

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in VRAX

All disclosures →

No recent disclosed trades by Congress in VRAX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VRAX

No recent insider (Form 4) filings in VRAX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VRAX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.